All News
If you don't know pt with inflammatory arthritis or CTD has fibromyalgia it will affect negatively. Ie pt is less likely to achieve remission target and ??overRx and v common. Pain and inflammation beget chronic pain in some. SP0119 Choy #EULAR2019 @RheumNow https://t.co/Ly9YA3VV9H
Janet Pope Janetbirdope ( View Tweet)
Rifampin makes Tofacitinib less effective. So use Isoniazid for latent Tb prophylaxis
Also speaker describing using once a week Rifapentine (drug interaction not an issue due to dosing) - I’ve no experience with this
#eular2019
Dr Irwin Lim _connectedcare ( View Tweet)
Good news for kids with scleroderma. Large database showing stability of SSc over time in kids SAT0479. Inception cohort. Improvement to follow over longer time. #EULAR2019 @RheumNow https://t.co/oK4Ejr9PQW
Janet Pope Janetbirdope ( View Tweet)
Almost a 50% of RA women will not improve during pregnancy and rates increases up to 70% in AS. So be aware that meds will be necessary in many pregnant women. Nelson-Piercy at Win&Hot session #EULAR2019 @RheumNow
Emilio Martin Mola emartinmola ( View Tweet)
Do you routinely ask about vaccinations in your pts? FRI0658 #EULAR2019 @RheumNow
Janet Pope Janetbirdope ( View Tweet)
Dr. Kevin Winthrop at #EULAR2019 during his infection lecture delivers the Pearl that Tofacitinib pts found to have Latent TB cannot take Rifampin - drug interaction w/ Tofa (lowers levels) https://t.co/LpoRbVC77J
Dr. John Cush RheumNow ( View Tweet)
Baricitinib long term clinical trial safety up to 7yrs #EULAR2019 https://t.co/jFKOrS28wz
Dr Irwin Lim _connectedcare ( View Tweet)
EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy
#EULAR2019 https://t.co/azj3ZPOxqb
ARD & RMD Open ARD_BMJ ( View Tweet)
In women with SLE on MMF, switch to AZA and wait 3 months prior to trying to conceive as some will flare with the switch. Catherine Nelson-Piercy. #EULAR2019
Rachel Black dr_rachelblack ( View Tweet)
Wellbeing measures in RA: a summary of Baracitinib vs Adalimumab #EULAR2019 https://t.co/0bYHLpzSrV
Dr Irwin Lim _connectedcare ( View Tweet)
ACR CRISS shows efficacy in ASSET (abatacept) trial in scleroderma. Another trial with positive CRISS. #EULAR2019 POSTER FR0327. @bmsnews https://t.co/6dTdehoAUe
Dr. Dinesh Khanna sclerodermaUM ( View Tweet)
Dr Nelson-Piercy illustrates drugs that can & can't be used during pregnancy. Win&Hot session #EULAR2019 @RheumNow https://t.co/C9g8tyBixj
Emilio Martin Mola emartinmola ( View Tweet)
So many factors contribute to disease activity. The scatterplot’s got scatter: at least for SpA, adalimumab drug concentrations are at most only one of those factors. #EULAR2019 FRI0381 from Groningen @RheumNow https://t.co/SaWg143ViT
David Liew drdavidliew ( View Tweet)
Busy day at Eular Madrid #EULAR2019 @RheumNow https://t.co/QB6vkbzvmW
Janet Pope Janetbirdope ( View Tweet)
Dr Alvin Wells - ACrossover Swithchiing study of the Jak inhibitor UPAdacitinib and adalimumab. OP0029. #EULAR2019 https://t.co/MqLtR8qmwJ
Dr. John Cush RheumNow ( View Tweet)
Dr. Atul Deodhar presents data showing that secukinumab treated ankylosing spondylitis patients respond better when treated early. #EULAR2019 FRI0388 https://t.co/7swe9vpRdl
Dr. John Cush RheumNow ( View Tweet)
Dr. Christopher Ritchlin - New Phenotypic and Biomarket Predictors of Psoriatic Arthritis. Presentations from #EULAR2019 https://t.co/Z4YRuJbr51
Dr. John Cush RheumNow ( View Tweet)
Pulse methylpred does not improve survival or relapse but is associated with increased morbidity in AAV. Raashid Luqmani. #EULAR2019 https://t.co/NJPvGyCO2l
Rachel Black dr_rachelblack ( View Tweet)
Rescreening for TB during bDMARDs might be a waste in a lot of countries, but in Romania it might be a different story (despite latent TB chemoprophylaxis). Infection risk depends on epidemiology #EULAR2019 FRI0076 @RheumNow https://t.co/2GuiW9oJkQ
David Liew drdavidliew ( View Tweet)
Dr. Artie Kavanaugh - New Prednisone Revelations from #EULAR2019 https://t.co/ChAjGJpjF2
Dr. John Cush RheumNow ( View Tweet)
